Vaxcyte, Inc. 5VA.F Stock
Vaxcyte, Inc. Price Chart
Vaxcyte, Inc. 5VA.F Financial and Trading Overview
| Vaxcyte, Inc. stock price | 62.5 EUR |
| Previous Close | 48 EUR |
| Open | 47.4 EUR |
| Bid | 47.4 EUR x N/A |
| Ask | 48.4 EUR x N/A |
| Day's Range | 47.4 - 47.4 EUR |
| 52 Week Range | 17.8 - 48.8 EUR |
| Volume | 40 EUR |
| Avg. Volume | 5 EUR |
| Market Cap | 4.44B EUR |
| Beta (5Y Monthly) | 0.956114 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.93 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 50.5 EUR |
5VA.F Valuation Measures
| Enterprise Value | 3.69B EUR |
| Trailing P/E | N/A |
| Forward P/E | -20.34335 |
| PEG Ratio (5 yr expected) | -1.07 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.0457497 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -14.119 |
Trading Information
Vaxcyte, Inc. Stock Price History
| Beta (5Y Monthly) | 0.956114 |
| 52-Week Change | 174.15% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 48.8 EUR |
| 52 Week Low | 17.8 EUR |
| 50-Day Moving Average | 41.57 EUR |
| 200-Day Moving Average | 37.94 EUR |
5VA.F Share Statistics
| Avg. Volume (3 month) | 5 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 93.71M |
| Float | 82.88M |
| Short Ratio | N/A |
| % Held by Insiders | 4.07% |
| % Held by Institutions | 90.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.41% |
| Return on Equity (ttm) | -37.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -22995000 EUR |
| EBITDA | -261520000 EUR |
| Net Income Avi to Common (ttm) | -244960992 EUR |
| Diluted EPS (ttm) | -3.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 822.04M EUR |
| Total Cash Per Share (mrq) | 8.77 EUR |
| Total Debt (mrq) | 16.59M EUR |
| Total Debt/Equity (mrq) | 1.76 EUR |
| Current Ratio (mrq) | 15.938 |
| Book Value Per Share (mrq) | 11.716 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -190584992 EUR |
| Levered Free Cash Flow (ttm) | -120237128 EUR |
Profile of Vaxcyte, Inc.
| Country | Germany |
| State | CA |
| City | San Carlos |
| Address | 825 Industrial Road |
| ZIP | 94070 |
| Phone | 650 837 0111 |
| Website | https://vaxcyte.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 158 |
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against these emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Q&A For Vaxcyte, Inc. Stock
What is a current 5VA.F stock price?
Vaxcyte, Inc. 5VA.F stock price today per share is 62.5 EUR.
How to purchase Vaxcyte, Inc. stock?
You can buy 5VA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vaxcyte, Inc.?
The stock symbol or ticker of Vaxcyte, Inc. is 5VA.F.
Which industry does the Vaxcyte, Inc. company belong to?
The Vaxcyte, Inc. industry is Biotechnology.
How many shares does Vaxcyte, Inc. have in circulation?
The max supply of Vaxcyte, Inc. shares is 110.1M.
What is Vaxcyte, Inc. Price to Earnings Ratio (PE Ratio)?
Vaxcyte, Inc. PE Ratio is now.
What was Vaxcyte, Inc. earnings per share over the trailing 12 months (TTM)?
Vaxcyte, Inc. EPS is -3.93 EUR over the trailing 12 months.
Which sector does the Vaxcyte, Inc. company belong to?
The Vaxcyte, Inc. sector is Healthcare.